Some medicines used in MS, including disease modifying drugs (DMDs), are manufactured in mainland Europe. The government has recognised that there is concern around getting these medicines into Britain if there is a no-deal Brexit, or if there is disruption around Brexit at the end of October.
The NHS England information webpage describes the arrangements that have been made to ensure that medicines remain accessible if there is a no-deal EU exit. This information is not specific to MS medication.
Existing Brexit arrangements include holding an extra six weeks of medicine stocks in the UK, as a buffer against an interruption in medicine supply, and ensuring extra transport capacity to get medicines into the UK.
Government recommendations for people who require medicines are as follows:
Get your prescription medicines as normal.
Keep ordering your repeat prescriptions, and take your medicines as recommended by your doctors. There is no need to change how often you order your medicines, how much of your medicines you order, or how frequently you take your medicines.
Don’t stockpile your own medicines.
If there is a shortage of your medicine, you might temporarily be prescribed with a different brand or formulation of the medicine to the one you are used to. You and the doctor who prescribed your medicine should be informed and be able to discuss your options for continuing treatment.
